In accordance with the increasing rate of COVID positive people all over the world, another vaccine named Novavax is developed by the Novavax and the Coalition for Epidemic Preparedness Innovations in short {CEPI} whose trials is undergoing in India under the branch of Covovax.
Reports given by the financial times
According to the reports given by the financial times on Thursday, this vaccine named Novavax might get approval from Europe’s Drug Regulator next week, and as per the view of the increasing COVID positivity rate, the World Health Organization has launched an Emergency use listing of this Covid vaccine to get the situation under control.
The people of Indonesia have already get vaccinated by this protein based vaccine last month whereas Japan hasn’t given approval to this vaccine yet, meanwhile, Takeda Pharmaceutical is manufacturing and distributing this vaccine among people.
If this vaccine will get approval then definitely the rate of Increasing COVID positive patients will decrease all over the world as it will be given to the children who are still not vaccinated by any vaccine. But if the parents will not take the responsibility of getting their child vaccinated then the same might not happen.
Read all the Latest News, Breaking News and Coronavirus News here.
